Concepedia

Shai Erlich

SE

Statistics

Publications

13

Citations

1.5K

H-Index

12

Active since

1995

Affiliations

Quark Pharmaceuticals (United States)(Current)

Icahn School of Medicine at Mount Sinai

Johns Hopkins University

Pfizer (United States)

Indiana University School of Medicine

Shai Erlich is an author at Quark Pharmaceuticals (United States) specializing in medicine, life sciences, and pharmacology.

Publications per year

1995–2021

13

Publications

13

Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease

Kenichi Horinouchi, Shai Erlich, Daniel P. Perl et al. · Nature Genetics · 1995 · 477 citations

Life Sciences, Biochemistry, Pathology +15

siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury

Bruce A. Molitoris, Pierre C. Dagher, Ruben M. Sandoval et al. · Journal of the American Society of Nephrology · 2009 · 338 citations · Full text

Medicine, Molecular Biology, Pharmacology +16

Dose-Ranging Evaluation of Intravitreal siRNA PF-04523655 for Diabetic Macular Edema (the DEGAS Study)

Quan Dong Nguyen, Ronald A. Schachar, Chudy I. Nduaka et al. · Investigative Ophthalmology & Visual Science · 2012 · 101 citations

Medicine, Ophthalmology, Pharmacotherapy +16

Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study

Matthias Thielmann, David Corteville, Gábor Szabó et al. · Circulation · 2021 · 92 citations · Full text

Medicine, Pharmacotherapy, Surgery +15

Toxicological and Pharmacokinetic Properties of Chemically Modified siRNAs Targeting p53 RNA Following Intravenous Administration

James D. Thompson, Douglas J. Kornbrust, Jeffrey W.-D. Foy et al. · Nucleic Acid Therapeutics · 2012 · 84 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +13

1–5 of 13